Olinvacimab
Product Specifications
CAS Number
2095504-49-5
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.979
Bioactivity
Olinvacimab (TTAC-0001) is a human monoclonal antibody targeting VEGFR-2/KDR with anti-angiogenic activity that blocks tumor angiogenesis and may be used to study solid tumors.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1138141 Inquire
Recombinant Bacillus subtilis Antilisterial bacteriocin subtilosin biosynthesis protein AlbG (albG)
Sign In for Pricing
View Details 
K2682408 1.0 µg DNA
ZNF32 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
OR29433 1 Each
3-nitro-N'- (2,3,3-trichloroallanoyl) benzohydrazide
Sign In for Pricing
View Details